BETA

Activities of Mireille D'ORNANO related to 2014/2207(INI)

Plenary speeches (1)

Safer healthcare in Europe (A8-0142/2015 - Piernicola Pedicini) FR
2016/11/22
Dossiers: 2014/2207(INI)

Amendments (33)

Amendment 8 #
Motion for a resolution
Recital C
C. whereas it is estimated that between 8 % and 12 % of patients admitted to hospitals in the EU suffer from adverse eventsmanifest shortcomings exist in hospitals in certain Member States as regards adverse events affecting patients admitted to them while receiving healthcare, and whereas nearly half of these events could be avoided;
2015/03/09
Committee: ENVI
Amendment 9 #
Motion for a resolution
Recital C a (new)
Ca. whereas the prevalence of these defects varies between Member States and whereas therefore Member States should be free to take measures appropriate to each national situation;
2015/03/09
Committee: ENVI
Amendment 17 #
Motion for a resolution
Recital E
E. whereas the current economic crisis isand the austerity measures imposed by the Commission are having a direct impact on patient safety, as many Member States have reduced budgets and staffing levels in their healthcare systems;
2015/03/09
Committee: ENVI
Amendment 22 #
Motion for a resolution
Recital F
F. whereas electronic health (eHealth) and home-care medical treatments have a high potential for improving the quality and efficiency of medical treatments while contributing to a patient-centred approach and better healthcare performance, and whereas electronic health cannot take the place of genuine consultations;
2015/03/09
Committee: ENVI
Amendment 26 #
Motion for a resolution
Recital G
G. whereas continuous training of doctors, and more generally of health professionals and hospital workers, is crucial to avoid adverse events, including adverse drug events (ADEs), which are estimated to cost the EU healthcare systems some EUR 2.7 billion per year in care expenses and account for 1.1 % of all hospitalisations in the EU;
2015/03/09
Committee: ENVI
Amendment 38 #
Motion for a resolution
Recital L
L. whereas one of the main causes of antimicrobial resistance is the misinappropriate use of antimicrobials, including antibiotics, and in particular their excessive use;
2015/03/09
Committee: ENVI
Amendment 44 #
Motion for a resolution
Recital M
M. whereas the use of antibiotics in animalspets or livestock can affect antibiotic resistance in humans, particularly because of the development of types of intensive farming which are conducive to the rapid contamination of a large number of animals and therefore to the use of large quantities of antibiotics;
2015/03/09
Committee: ENVI
Amendment 58 #
Motion for a resolution
Recital N
N. whereas antimicrobial resistance has increased worldwide for bacterial pathogens, leading to increasing prevalence of HAIs and treatment failures in human and animal infectious diseases at national, European and international levels; whereas the free movement of persons in the Schengen area contributes to the rapid spread of multidrug-resistant diseases; whereas this applies to the worrying phenomenon of multidrug-resistant tuberculosis, which particularly affects illegal immigrant populations, who in many cases are treated only at a late stage;
2015/03/09
Committee: ENVI
Amendment 104 #
Motion for a resolution
Paragraph 1
1. Welcomes the latest measures put in place by Member States to improve general patient safety and reduce the incidence of HAIs, and more particularly the progress made by Member States in developing patient safety strategies and reporting and learning systems, and recognises the national level as the only level capable of formulating and implementing public health policies;
2015/03/09
Committee: ENVI
Amendment 106 #
Motion for a resolution
Paragraph 2
2. Notes, however, that the second implementation report still shows uneven progress among Member States oObserves that, in certain Member States, shortcomings may exist in patient safety, and regrets the fact that some Member States have obviouslybeen compelled to slowed down implementation of the Council recommendations because of financial constraints resulting from the economic crisis;
2015/03/09
Committee: ENVI
Amendment 111 #
Motion for a resolution
Paragraph 3
3. Calls on Member States to make sure thatthe Commission to abandon austerity measures which could damage the healthcare system is not affected by austerity measures ands of the Member States and calls on Member States to ensure a sufficient number of healthcare professionals specialised in infection prevention and control, as well as hospital hygiene for a more patient-centred approach;
2015/03/09
Committee: ENVI
Amendment 114 #
Motion for a resolution
Paragraph 4
4. Recommends that the Commission continue monitoring the implementation of the provisions on patient safety in the Member States;deleted
2015/03/09
Committee: ENVI
Amendment 120 #
Motion for a resolution
Paragraph 6 – point a
(a) continue their efforts to improve patient safety by taking, if they have not already done so, new measures in order to fully implement the Council’s recommendations;
2015/03/09
Committee: ENVI
Amendment 146 #
Motion for a resolution
Paragraph 7
7. Highlights the potential benefits of eHealth in reducing adverse events by tracking information flows and improving the understanding of medical processes, as well as through digital prescriptions and alerts on drug interaction; calls on the Commission and the Member States to further explore the possibilities offered by eHealth in the area of patient safety;
2015/03/09
Committee: ENVI
Amendment 156 #
Motion for a resolution
Paragraph 9
9. Calls on the European Medicines Agency (EMA) to develop guidelines on the off-label/unlicensed use of medicines based on medical need, as well as to compile a list of off-label medicines in use despite licenauthorised alternatives;
2015/03/09
Committee: ENVI
Amendment 167 #
Motion for a resolution
Paragraph 10
10. Invites the Member States to improve their reporting systems for adverse events and medical errors by developing measures that encourage accurate, blame-free and anonymous reporting by health professionals and patients; recalls the need to provide regular feedback to health professionals involved in reporting;
2015/03/09
Committee: ENVI
Amendment 173 #
Motion for a resolution
Paragraph 12
12. Invites the Member States to be more rigorous in verifying and enforcing the ban on non-medical external staff performing medical treatment; points out that this is happening with employees of companies that provide sophisticated medical machinery to hospitals; therefore, calls onsuggests that Member States to introduce a mandatory registration of the presence of product specialists during therapeutic treatments;
2015/03/09
Committee: ENVI
Amendment 178 #
Motion for a resolution
Paragraph 13
13. Calls on the Member States to provide for collective redress mechanisms in their national law, in accordance with the legal systems and traditions of each Member State, so as to allow the introduction of fair compensation systems for patients who have suffered an HAI or a medical error;
2015/03/09
Committee: ENVI
Amendment 180 #
Motion for a resolution
Paragraph 14
14. Invites the Commission to report onproduce a report reviewing national practices of collective redress in HAI-related cases and to launch a consultation aimed at debating the possibility of harmonising collective redress in HAI cases at European levelinform Parliament of the results;
2015/03/09
Committee: ENVI
Amendment 183 #
Motion for a resolution
Paragraph 15
15. Welcomes the Commission’s workeveryday work of the Member States’ medical teams on antimicrobial resistance and on the prevention and control of HAIs, as well as the coordination and surveillance efforts of the European Centre for Disease Prevention and Control (ECDC);
2015/03/09
Committee: ENVI
Amendment 200 #
Motion for a resolution
Paragraph 19
19. Welcomes and encourages further research for new antimicrobial drugs, in particular antibiotics with activity against prevalent multidrug-resistant Gram- negative bacteria such as K. pneumoniae and Acinetobacter, as well as for alternative methods aimed at fighting HAIs without using antibiotics, particularly involving the use of natural products;
2015/03/09
Committee: ENVI
Amendment 201 #
Motion for a resolution
Paragraph 19
19. Welcomes and encourages further research for new antimicrobial drugs, in particular antibiotics with activity against prevalent multidrug-resistant Gram- negative bacteria such as K. pneumoniae and Acinetobacter, as well as for alternative methods aimed at fighting HAIs without using antibiotics; recalls that the simplest hygiene measures are often the least costly and nonetheless effective and that they are a matter of remembering actions which are common sense on the part of patients themselves and people around them;
2015/03/09
Committee: ENVI
Amendment 210 #
Motion for a resolution
Paragraph 20
20. Considers it of paramount importance that the Commission should ensure the continuation of the EU Action Plan on Antimicrobial Resistance post-2017, with an emphasis on theMember States should encourage measures to prevention and control of healthcare-associated infections;
2015/03/09
Committee: ENVI
Amendment 221 #
Motion for a resolution
Paragraph 21
21. Calls on the Member States to promote the responsible and sensible use in human medicine of all antimicrobial agents and in particular antibiotics;Does not affect the English version.
2015/03/09
Committee: ENVI
Amendment 231 #
Motion for a resolution
Paragraph 22 – introductory part
22. UrgesCalls on the Member States to implement or developstudy measures which have the following measurobjectives:
2015/03/09
Committee: ENVI
Amendment 235 #
Motion for a resolution
Paragraph 22 – point a
(a) regulatationalise the prescription of antibiotics for treatment or prophylaxis so that an appropriate use of medicines is ensured, specifying the therapeutic objective and selecting the appropriate drug therapy;
2015/03/09
Committee: ENVI
Amendment 243 #
Motion for a resolution
Paragraph 22 – point b
(b) improve regulateion of the sale of antibiotics so that patients can buy only the specific quantity of antibiotics as prescribed by their doctors;
2015/03/09
Committee: ENVI
Amendment 253 #
Motion for a resolution
Paragraph 22 – point e
(e) intensify infection control, in particular from a cross-border perspective, by properly screening patients transferred from a country/region/hospital known for its high prevalence of multidrug-resistant bacteria or even apply Article 2(2) of the Convention implementing the Schengen Agreement;
2015/03/09
Committee: ENVI
Amendment 256 #
Motion for a resolution
Paragraph 22 – point e a (new)
(ea) leave Member States free to institute the appropriate measures at their national borders concerning migrants from high- risk areas;
2015/03/09
Committee: ENVI
Amendment 273 #
Motion for a resolution
Paragraph 23 – introductory part
23. Calls on the Member States to introduce or developstudy measures which have the following measurobjectives:
2015/03/09
Committee: ENVI
Amendment 299 #
Motion for a resolution
Paragraph 24
24. Urges the Member States to regulate any conflicts of interest involving veterinarians who both sell and prescribeRecalls that decoupling the prescription and sale of antibiotics by veterinarians is not the solution to abusive prescribing practices and that veterinarians have already taken steps to reduce prescribing of antibiotics, with encouraging results as regards the resistance observed; calls on Member States to take measures to avoid promoting types of farming in which several thousand animals are concentrated in one place, which increase health risks and the consumption of antibiotics;
2015/03/09
Committee: ENVI
Amendment 303 #
Motion for a resolution
Paragraph 24 a (new)
24a. Calls on Member States to improve the training of veterinarians, who are major prescribers of antibiotics, particularly by encouraging them to exploit diagnostic tools to identify the most appropriate antibiotic;
2015/03/09
Committee: ENVI
Amendment 318 #
Motion for a resolution
Paragraph 26
26. Calls on the Commission and the Member States to further engage in a dialogue with all stakeholders and develop a coordinated, comprehensive and sustainable EU strategy for patient safety, as well as to put forward concrete solutions to be implemented at EU, national, regional, local and/or primary care levels; reiterates that public health policies must be formulated primarily at national level;
2015/03/09
Committee: ENVI